[ad_1]
Beijing, January 18, 2022 /PR Newswire/ –Open December 7, 2021, MIOK artificial cornea used to be Approved by NMPA, China’s drug and medical device regulatory agency. MIOK artificial cornea is the first approved artificial cornea in the world. It does not require co-implantation of artificial cornea. It is of great significance to the 60 million corneal blind patients in the world, because MIOK artificial cornea makes it no longer impossible for corneal patients to restore their vision and relieve their families. burden.
Corneal transplantation is one of the key ways to restore vision in patients with corneal blindness. However, the risk of corneal transplant failure and post-server complications is high, often due to a complex immune response that is incompatible with the transplanted organ. Other artificial corneas that require co-implantation with a donor cornea are not immune to this risk. Therefore, MIOK Keratopprothesis is an artificial cornea made of 100% non-biological material and does not require co-implantation with a donor cornea, ideal for treating patients with corneal blindness.
MIOK corneal prosthesis is mainly composed of transparent PMMA plastic with excellent optical properties and tissue…
The full story is available on Benzinga.com
[ad_2]
Source link
